• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺癌衍生的间充质干细胞促进肿瘤生长和免疫抑制。

Human lung cancer-derived mesenchymal stem cells promote tumor growth and immunosuppression.

机构信息

Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China.

Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, Italy.

出版信息

Biol Direct. 2024 May 16;19(1):39. doi: 10.1186/s13062-024-00479-w.

DOI:10.1186/s13062-024-00479-w
PMID:38755705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11097554/
Abstract

BACKGROUND

The presence of mesenchymal stem cells has been confirmed in some solid tumors where they serve as important components of the tumor microenvironment; however, their role in cancer has not been fully elucidated. The aim of this study was to investigate the functions of mesenchymal stem cells isolated from tumor tissues of patients with non-small cell lung cancer.

RESULTS

Human lung cancer-derived mesenchymal stem cells displayed the typical morphology and immunophenotype of mesenchymal stem cells; they were nontumorigenic and capable of undergoing multipotent differentiation. These isolated cells remarkably enhanced tumor growth when incorporated into systems alongside tumor cells in vivo. Importantly, in the presence of mesenchymal stem cells, the ability of peripheral blood mononuclear cell-derived natural killer and activated T cells to mediate tumor cell destruction was significantly compromised.

CONCLUSION

Collectively, these data support the notion that human lung cancer-derived mesenchymal stem cells protect tumor cells from immune-mediated destruction by inhibiting the antitumor activities of natural killer and T cells.

摘要

背景

间充质干细胞存在于一些实体肿瘤中,它们是肿瘤微环境的重要组成部分;然而,它们在癌症中的作用尚未完全阐明。本研究旨在探讨从非小细胞肺癌患者肿瘤组织中分离的间充质干细胞的功能。

结果

人肺癌衍生的间充质干细胞表现出间充质干细胞的典型形态和免疫表型;它们无致瘤性且能够进行多能分化。这些分离的细胞在体内与肿瘤细胞一起纳入系统时显著增强了肿瘤的生长。重要的是,在间充质干细胞存在的情况下,外周血单个核细胞衍生的自然杀伤细胞和活化 T 细胞介导肿瘤细胞破坏的能力显著受损。

结论

总之,这些数据支持这样一种观点,即人肺癌衍生的间充质干细胞通过抑制自然杀伤细胞和 T 细胞的抗肿瘤活性来保护肿瘤细胞免受免疫介导的破坏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/98fa594ab9ac/13062_2024_479_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/5975c1026434/13062_2024_479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/f2fb0c6f3803/13062_2024_479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/2d66fb52b265/13062_2024_479_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/c859de5991bb/13062_2024_479_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/381c7aefa8a4/13062_2024_479_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/e836cb9fef36/13062_2024_479_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/78c7ad5ed7d4/13062_2024_479_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/98fa594ab9ac/13062_2024_479_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/5975c1026434/13062_2024_479_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/f2fb0c6f3803/13062_2024_479_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/2d66fb52b265/13062_2024_479_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/c859de5991bb/13062_2024_479_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/381c7aefa8a4/13062_2024_479_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/e836cb9fef36/13062_2024_479_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/78c7ad5ed7d4/13062_2024_479_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9869/11097554/98fa594ab9ac/13062_2024_479_Fig8_HTML.jpg

相似文献

1
Human lung cancer-derived mesenchymal stem cells promote tumor growth and immunosuppression.人肺癌衍生的间充质干细胞促进肿瘤生长和免疫抑制。
Biol Direct. 2024 May 16;19(1):39. doi: 10.1186/s13062-024-00479-w.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.白细胞介素-12与接受自体外周血干细胞移植的肺癌和恶性淋巴瘤的比较。
J Cancer Res Clin Oncol. 2002 Jan;128(1):29-36. doi: 10.1007/s004320100270. Epub 2001 Nov 1.
4
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.肿瘤相关中性粒细胞招募巨噬细胞和 T 调节细胞促进肝细胞癌进展和索拉非尼耐药。
Gastroenterology. 2016 Jun;150(7):1646-1658.e17. doi: 10.1053/j.gastro.2016.02.040. Epub 2016 Feb 26.
5
Simvastatin inhibits the immunosuppressive effects of endometrial cancer-associated mesenchymal stem cells through TGF-β2/SMAD2/3 signaling and reduces tumor growth.辛伐他汀通过TGF-β2/SMAD2/3信号通路抑制子宫内膜癌相关间充质干细胞的免疫抑制作用并减少肿瘤生长。
Sci Rep. 2025 Jul 1;15(1):21533. doi: 10.1038/s41598-025-08686-9.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis.NG2 表达细胞亚群在骨髓间充质干细胞中作为肝纤维化/肝硬化新型治疗工具的新进展。
Stem Cell Res Ther. 2024 Jul 6;15(1):199. doi: 10.1186/s13287-024-03817-x.
8
Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer.非小细胞肺癌中肿瘤内中性粒细胞与淋巴细胞比值与循环中性粒细胞与淋巴细胞比值呈正相关。
J Immunother Cancer. 2025 Jun 24;13(6):e011458. doi: 10.1136/jitc-2025-011458.
9
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).环状 RNA circ-CPA4/let-7 miRNA/PD-L1 轴调控非小细胞肺癌(NSCLC)中的细胞生长、干性、耐药性和免疫逃逸。
J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1.
10
Mesenchymal stem/stromal cells from human pluripotent stem cell-derived brain organoid enhance the ex vivo expansion and maintenance of hematopoietic stem/progenitor cells.人多能干细胞衍生脑类器官中的间充质干细胞/基质细胞增强了造血干/祖细胞的体外扩增和维持。
Stem Cell Res Ther. 2024 Mar 5;15(1):68. doi: 10.1186/s13287-023-03624-w.

引用本文的文献

1
Evolution of cell therapies derived from adipose tissue: historical perspectives, current development trends and future directions.源自脂肪组织的细胞疗法的演变:历史视角、当前发展趋势及未来方向。
Biol Direct. 2025 Aug 27;20(1):95. doi: 10.1186/s13062-025-00682-3.
2
Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies.解析乳腺癌肿瘤微环境:影响自然杀伤细胞功能的关键因素及治疗策略
Int J Biol Sci. 2025 Mar 24;21(6):2606-2628. doi: 10.7150/ijbs.108803. eCollection 2025.
3
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications.间充质干细胞与自然杀伤细胞之间的细胞串扰机制:治疗意义。
J Cell Physiol. 2021 Apr;236(4):2413-2429. doi: 10.1002/jcp.30038. Epub 2020 Sep 6.
2
Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis.间质干细胞与肿瘤细胞的相互调节促进肺癌转移。
EBioMedicine. 2018 Mar;29:128-145. doi: 10.1016/j.ebiom.2018.02.017. Epub 2018 Feb 23.
3
Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.
不同间充质干细胞及其衍生外泌体在代谢功能障碍相关脂肪性肝病中的治疗潜力。
Front Endocrinol (Lausanne). 2025 Apr 3;16:1558194. doi: 10.3389/fendo.2025.1558194. eCollection 2025.
4
Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies.工程间充质干细胞治疗卵巢早衰:克服挑战和创新治疗策略。
Theranostics. 2024 Oct 7;14(17):6487-6515. doi: 10.7150/thno.102641. eCollection 2024.
人结直肠癌细胞来源的间充质干细胞通过 IL-6/JAK2/STAT3 信号促进结直肠癌细胞的进展。
Cell Death Dis. 2018 Jan 18;9(2):25. doi: 10.1038/s41419-017-0176-3.
4
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.肿瘤相关间充质干细胞:新兴的治疗靶点。
Nat Rev Drug Discov. 2017 Jan;16(1):35-52. doi: 10.1038/nrd.2016.193. Epub 2016 Nov 4.
5
Tumors: wounds that do not heal-redux.肿瘤:永不愈合的创伤。
Cancer Immunol Res. 2015 Jan;3(1):1-11. doi: 10.1158/2326-6066.CIR-14-0209.
6
Competition between human cells by entosis.通过细胞内吞作用实现的人类细胞间竞争。
Cell Res. 2014 Nov;24(11):1299-310. doi: 10.1038/cr.2014.138. Epub 2014 Oct 24.
7
PD-L1 expression in triple-negative breast cancer.PD-L1 在三阴性乳腺癌中的表达。
Cancer Immunol Res. 2014 Apr;2(4):361-70. doi: 10.1158/2326-6066.CIR-13-0127. Epub 2014 Jan 10.
8
Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.结直肠癌相关成纤维细胞分泌的白细胞介素 6 对肿瘤血管生成至关重要:抗白细胞介素 6 受体抗体抑制血管生成并抑制肿瘤-基质相互作用。
Br J Cancer. 2014 Jan 21;110(2):469-78. doi: 10.1038/bjc.2013.748. Epub 2013 Dec 17.
9
Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.人胎盘间充质干细胞(pMSCs)通过将巨噬细胞分化从炎症 M1 型转向抗炎 M2 型,发挥免疫抑制细胞的作用。
Stem Cell Rev Rep. 2013 Oct;9(5):620-41. doi: 10.1007/s12015-013-9455-2.
10
CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα.肿瘤诱导的间充质基质细胞通过 CCR2 依赖性招募巨噬细胞促进肿瘤发展,这一过程可被 TNFα 模拟。
Cell Stem Cell. 2012 Dec 7;11(6):812-24. doi: 10.1016/j.stem.2012.08.013. Epub 2012 Nov 15.